| 1 |
Wu H, Jiang X, Li Y, Dong Y, Zheng J, Li L, Li Y, Wang J, Lin X, Zhang X, Zhang T, Gu Z, Gao J. Hybrid stem cell-derived bioresponsive vesicles for effective inflamed blood-brain barrier targeting delivery. Nano Today 2023;49:101800. [DOI: 10.1016/j.nantod.2023.101800] [Reference Citation Analysis]
|
| 2 |
Dai J, Wu M, Xu Y, Yao H, Lou X, Hong Y, Zhou J, Xia F, Wang S. Platelet membrane camouflaged AIEgen-mediated photodynamic therapy improves the effectiveness of anti-PD-L1 immunotherapy in large-burden tumors. Bioeng Transl Med 2023;8:e10417. [PMID: 36925700 DOI: 10.1002/btm2.10417] [Reference Citation Analysis]
|
| 3 |
Zhang J, Han J, Li H, Li Z, Zou P, Li J, Zhao T, Che J, Yang Y, Yang M, Wang Y, Gong W, Li Z, Li L, Gao C, Xiao H. Lymphocyte Membrane- and 12p1-Dual-Functionalized Nanoparticles for Free HIV-1 Trapping and Precise siRNA Delivery into HIV-1-Infected Cells. Adv Sci (Weinh) 2023;:e2300282. [PMID: 36755201 DOI: 10.1002/advs.202300282] [Reference Citation Analysis]
|
| 4 |
Davies OG, Williams S, Goldie K. The therapeutic and commercial landscape of stem cell vesicles in regenerative dermatology. J Control Release 2023;353:1096-106. [PMID: 36535543 DOI: 10.1016/j.jconrel.2022.12.025] [Reference Citation Analysis]
|
| 5 |
Song Y, Zheng X, Hu J, Ma S, Li K, Chen J, Xu X, Lu X, Wang X. Recent advances of cell membrane-coated nanoparticles for therapy of bacterial infection. Front Microbiol 2023;14:1083007. [PMID: 36876074 DOI: 10.3389/fmicb.2023.1083007] [Reference Citation Analysis]
|
| 6 |
Yin T, Liu Y, Ji W, Zhuang J, Chen X, Gong B, Chu J, Liang W, Gao J, Yin Y. Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease. Theranostics 2023;13:1264-85. [PMID: 36923533 DOI: 10.7150/thno.81860] [Reference Citation Analysis]
|
| 7 |
Yang XY, Zhang JG, Zhou QM, Yu JN, Lu YF, Wang XJ, Zhou JP, Ding XF, Du YZ, Yu RS. Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer. J Nanobiotechnology 2022;20:524. [PMID: 36496411 DOI: 10.1186/s12951-022-01738-6] [Reference Citation Analysis]
|
| 8 |
Ravi SP, Shamiya Y, Chakraborty A, Coyle A, Zahid AA, Wang J, Boutilier MSH, Ho EA, Paul A. Controlling Differentiation of Adult Stem Cells Via Cell-Derived Nanoparticles: Implications in Bone Repair. ACS Appl Nano Mater 2022. [DOI: 10.1021/acsanm.2c03657] [Reference Citation Analysis]
|
| 9 |
Huang H, Sun M, Liu M, Pan S, Liu P, Cheng Z, Li J, Xu H, Liu F, Pang Z. Full encapsulation of oncolytic virus using hybrid erythroctye-liposome membranes for augmented anti-refractory tumor effectiveness. Nano Today 2022;47:101671. [DOI: 10.1016/j.nantod.2022.101671] [Reference Citation Analysis]
|
| 10 |
Chen C, Zhong W, Du S, Li Y, Zeng Y, Liu K, Yang J, Guan X, Han X. Intelligent nanotherapeutic strategies for the delivery of CRISPR system. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.12.013] [Reference Citation Analysis]
|
| 11 |
Yan J, Fei W, Song Q, Zhu Y, Bu N, Wang L, Zhao M, Zheng X. Cell membrane-camouflaged PLGA biomimetic system for diverse biomedical application. Drug Deliv 2022;29:2296-319. [PMID: 35861175 DOI: 10.1080/10717544.2022.2100010] [Reference Citation Analysis]
|
| 12 |
Fan X, Wang K, Lu Q, Lu Y, Liu F, Li L, Li S, Ye H, Zhao J, Cao L, Zhang H, He Z, Sun J. Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment. Acta Biomater 2022;154:412-23. [PMID: 36280028 DOI: 10.1016/j.actbio.2022.10.031] [Reference Citation Analysis]
|
| 13 |
Achmad H, Saleh Ibrahim Y, Mohammed Al-taee M, Gabr GA, Waheed Riaz M, Hamoud Alshahrani S, Alexis Ramírez-coronel A, Turki Jalil A, Setia Budi H, Sawitri W, Elena Stanislavovna M, Gupta J. Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting. International Immunopharmacology 2022;113:109434. [DOI: 10.1016/j.intimp.2022.109434] [Reference Citation Analysis]
|
| 14 |
Gao M, Yang T, Qin W, Wang Q, Huang M, Peng H, Shao M, Yao W, Yi X, Sun G, He X. Cell Membrane-Anchoring Nano-Photosensitizer for Light-Controlled Calcium-Overload and Tumor-Specific Synergistic Therapy. Small 2022;18:e2204689. [PMID: 36180398 DOI: 10.1002/smll.202204689] [Reference Citation Analysis]
|
| 15 |
Wang L, Shi Y, Jiang J, Li C, Zhang H, Zhang X, Jiang T, Wang L, Wang Y, Feng L. Micro-Nanocarriers Based Drug Delivery Technology for Blood-Brain Barrier Crossing and Brain Tumor Targeting Therapy. Small 2022;18:e2203678. [PMID: 36103614 DOI: 10.1002/smll.202203678] [Reference Citation Analysis]
|
| 16 |
Park KS, Bergqvist M, Lässer C, Lötvall J. Targeting Myd88 using peptide-loaded mesenchymal stem cell membrane-derived synthetic vesicles to treat systemic inflammation. J Nanobiotechnology 2022;20:451. [PMID: 36243859 DOI: 10.1186/s12951-022-01660-x] [Reference Citation Analysis]
|
| 17 |
Nazli A, He DL, Liao D, Khan MZI, Huang C, He Y. Strategies and progresses for enhancing targeted antibiotic delivery. Adv Drug Deliv Rev 2022;189:114502. [PMID: 35998828 DOI: 10.1016/j.addr.2022.114502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Blay V, Li X, Gerlach J, Urbina F, Ekins S. Combining DELs and machine learning for toxicology prediction. Drug Discov Today 2022;27:103351. [PMID: 36096360 DOI: 10.1016/j.drudis.2022.103351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Kumar S, Karmacharya M, Cho Y. Bridging the Gap between Nonliving Matter and Cellular Life. Small. [DOI: 10.1002/smll.202202962] [Reference Citation Analysis]
|
| 20 |
Bigaj-józefowska MJ, Grześkowiak BF. Polymeric nanoparticles wrapped in biological membranes for targeted anticancer treatment. European Polymer Journal 2022;176:111427. [DOI: 10.1016/j.eurpolymj.2022.111427] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 21 |
Wang X, Li C, Wang Y, Chen H, Zhang X, Luo C, Zhou W, Li L, Teng L, Yu H, Wang J. Smart drug delivery systems for precise cancer therapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.013] [Reference Citation Analysis]
|
| 22 |
Zhang E, Phan P, Zhao Z. Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Li Y, Ruan S, Guo J, He Z, Xia Q, Wu T, Wang Z, Li Z, Hu H, Jing Q, Hou X, He Y, Zhang B, Feng N, Zhang Y. B16F10 Cell Membrane-Based Nanovesicles for Melanoma Therapy Are Superior to Hyaluronic Acid-Modified Nanocarriers. Mol Pharm 2022. [PMID: 35850109 DOI: 10.1021/acs.molpharmaceut.2c00212] [Reference Citation Analysis]
|
| 24 |
Prasad R, Conde J. Bioinspired soft nanovesicles for site‐selective cancer imaging and targeted therapies. WIREs Nanomed Nanobiotechnol 2022;14. [DOI: 10.1002/wnan.1792] [Reference Citation Analysis]
|
| 25 |
Khosravi N, Pishavar E, Baradaran B, Oroojalian F, Mokhtarzadeh A. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics. J Control Release 2022;348:706-22. [PMID: 35732250 DOI: 10.1016/j.jconrel.2022.06.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Yao Y, Chen H, Tan N. Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy. Acta Pharmaceutica Sinica B 2022;12:2103-19. [DOI: 10.1016/j.apsb.2021.10.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 28 |
Zhang F, Mundaca-Uribe R, Askarinam N, Li Z, Gao W, Zhang L, Wang J. Biomembrane-Functionalized Micromotors: Biocompatible Active Devices for Diverse Biomedical Applications. Adv Mater 2022;34:e2107177. [PMID: 34699649 DOI: 10.1002/adma.202107177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 29 |
Zeng Y, Li S, Zhang S, Wang L, Yuan H, Hu F. Cell membrane coated-nanoparticles for cancer immunotherapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 30 |
Wang Y, Zhao Z, Liu C, Hao M, Kong C, Zhao X, Gao Y, Zhang Y, Cui W, Zhang C, Jiang J. B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma. IJN 2022;Volume 17:855-68. [DOI: 10.2147/ijn.s338488] [Reference Citation Analysis]
|
| 31 |
Zhang L, Zhu Y, Wei X, Chen X, Li Y, Zhu Y, Xia J, Huang Y, Huang Y, Wang J, Pang Z. Nanoplateletsomes restrain metastatic tumor formation through decoy and active targeting in a preclinical mouse model. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.01.005] [Reference Citation Analysis]
|
| 32 |
Gültekin HE, Oner E, İlhan M, Karpuz M. Nanovesicles for intravenous drug delivery. Applications of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91865-7.00018-3] [Reference Citation Analysis]
|
| 33 |
Nair A, Bu J, Rawding PA, Do SC, Li H, Hong S. Cytochalasin B Treatment and Osmotic Pressure Enhance the Production of Extracellular Vesicles (EVs) with Improved Drug Loading Capacity. Nanomaterials (Basel) 2021;12:3. [PMID: 35009953 DOI: 10.3390/nano12010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Naskar A, Cho H, Lee S, Kim KS. Biomimetic Nanoparticles Coated with Bacterial Outer Membrane Vesicles as a New-Generation Platform for Biomedical Applications. Pharmaceutics 2021;13:1887. [PMID: 34834302 DOI: 10.3390/pharmaceutics13111887] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 35 |
Lv Y, He W, Wu W. Editorial of Special Issue of Hot Topic Reviews in Drug Delivery. Acta Pharm Sin B 2021;11:2094-5. [PMID: 34522578 DOI: 10.1016/j.apsb.2021.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
